TLK2
Basic information
Region (hg38): 17:62458658-62615481
Links
Phenotypes
GenCC
Source:
- intellectual disability, autosomal dominant 57 (Moderate), mode of inheritance: AD
- intellectual disability, autosomal dominant 57 (Strong), mode of inheritance: AD
- intellectual disability, autosomal dominant 57 (Definitive), mode of inheritance: AD
- intellectual disability, autosomal dominant 57 (Strong), mode of inheritance: AD
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Intellectual developmental disorder, autosomal dominant 57 | AD | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Craniofacial; Musculoskeletal; Neurologic | 27479843; 29861108 |
ClinVar
This is a list of variants' phenotypes submitted to
- not provided (16 variants)
- Intellectual disability, autosomal dominant 57 (16 variants)
- Inborn genetic diseases (4 variants)
- Neurodevelopmental disorder (1 variants)
- See cases (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the TLK2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 8 | |||||
missense | 16 | 55 | 75 | |||
nonsense | 14 | 20 | ||||
start loss | 0 | |||||
frameshift | 10 | 15 | ||||
inframe indel | 3 | |||||
splice donor/acceptor (+/-2bp) | 12 | |||||
splice region | 1 | 7 | 3 | 11 | ||
non coding | 12 | |||||
Total | 32 | 30 | 68 | 14 | 1 |
Variants in TLK2
This is a list of pathogenic ClinVar variants found in the TLK2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
17-62479268-AGCG-A | not specified | Likely benign (Jan 02, 2020) | ||
17-62479291-G-T | Uncertain significance (Jun 21, 2022) | |||
17-62479511-T-TGGGGCCG | Intellectual disability, autosomal dominant 57 | Conflicting classifications of pathogenicity (Jan 01, 2024) | ||
17-62479525-G-C | Likely benign (Jun 01, 2024) | |||
17-62481145-G-T | Inborn genetic diseases | Uncertain significance (Apr 26, 2023) | ||
17-62481152-C-T | Likely benign (Jun 01, 2022) | |||
17-62481156-C-T | Intellectual disability, autosomal dominant 57 | Likely pathogenic (Sep 22, 2024) | ||
17-62481159-C-T | Intellectual disability, autosomal dominant 57 | Uncertain significance (Jul 07, 2020) | ||
17-62481159-CG-C | Intellectual disability, autosomal dominant 57 | Pathogenic (Jan 08, 2021) | ||
17-62481162-C-T | Intellectual disability, autosomal dominant 57 | Pathogenic (Oct 15, 2018) | ||
17-62481181-G-C | Uncertain significance (Apr 01, 2021) | |||
17-62481192-G-A | Inborn genetic diseases | Likely benign (Jan 19, 2024) | ||
17-62481207-GT-G | Intellectual disability, autosomal dominant 57 | Uncertain significance (Mar 03, 2022) | ||
17-62520785-A-G | Uncertain significance (Apr 01, 2023) | |||
17-62520815-G-A | Inborn genetic diseases | Uncertain significance (Dec 09, 2023) | ||
17-62520852-G-A | not specified | Uncertain significance (Mar 13, 2024) | ||
17-62522199-G-A | Uncertain significance (Aug 01, 2019) | |||
17-62522213-A-G | Intellectual disability | Uncertain significance (May 28, 2020) | ||
17-62522214-A-G | Uncertain significance (Nov 28, 2022) | |||
17-62522224-T-G | Uncertain significance (Feb 14, 2020) | |||
17-62522231-C-T | Intellectual disability, autosomal dominant 57 | Pathogenic (Feb 25, 2024) | ||
17-62522237-C-T | Uncertain significance (Mar 22, 2023) | |||
17-62522252-G-T | Intellectual disability, autosomal dominant 57 | Pathogenic (Oct 15, 2018) | ||
17-62523126-A-G | Likely benign (Apr 01, 2024) | |||
17-62523136-A-C | Uncertain significance (Jan 24, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
TLK2 | protein_coding | protein_coding | ENST00000346027 | 21 | 156824 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.00 | 5.65e-8 | 125736 | 0 | 5 | 125741 | 0.0000199 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 4.49 | 148 | 401 | 0.369 | 0.0000217 | 4917 |
Missense in Polyphen | 12 | 113.47 | 0.10575 | 1576 | ||
Synonymous | 0.0259 | 145 | 145 | 0.997 | 0.00000802 | 1353 |
Loss of Function | 6.62 | 2 | 55.0 | 0.0364 | 0.00000351 | 609 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000267 | 0.0000264 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.000329 | 0.000326 |
dbNSFP
Source:
- Function
- FUNCTION: Serine/threonine-protein kinase involved in the process of chromatin assembly and probably also DNA replication, transcription, repair, and chromosome segregation. Phosphorylates the chromatin assembly factors ASF1A AND ASF1B. Phosphorylation of ASF1A prevents its proteasome-mediated degradation, thereby enhancing chromatin assembly. Negative regulator of amino acid starvation-induced autophagy. {ECO:0000269|PubMed:10523312, ECO:0000269|PubMed:11470414, ECO:0000269|PubMed:12660173, ECO:0000269|PubMed:12955071, ECO:0000269|PubMed:20016786, ECO:0000269|PubMed:22354037, ECO:0000269|PubMed:9427565}.;
- Pathway
- miRNA Regulation of DNA Damage Response;DNA Damage Response
(Consensus)
Recessive Scores
- pRec
- 0.0999
Intolerance Scores
- loftool
- 0.156
- rvis_EVS
- -0.27
- rvis_percentile_EVS
- 34.32
Haploinsufficiency Scores
- pHI
- 0.367
- hipred
- Y
- hipred_score
- 0.817
- ghis
- 0.564
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- H
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.451
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Tlk2
- Phenotype
Gene ontology
- Biological process
- regulation of chromatin assembly or disassembly;chromatin organization;protein phosphorylation;cellular response to DNA damage stimulus;cell cycle;chromosome segregation;negative regulation of autophagy;peptidyl-serine phosphorylation;negative regulation of proteasomal ubiquitin-dependent protein catabolic process;intracellular signal transduction;cellular response to gamma radiation
- Cellular component
- nucleus;intermediate filament;perinuclear region of cytoplasm
- Molecular function
- protein serine/threonine kinase activity;protein binding;ATP binding